| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 9e-05 |